Showing results (61-70 of 94) with videos related to
Sort By:
Pageof 10
Journal of Internal Medicine|November 22, 2025
Different eGFR markers and prediction of cardiovascular riskMaria Tydén, Gorav Batra, Bengt Fellström, et al.European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|July 15, 2026
Impact of Paclitaxel Coated Devices on Limb Salvage and Target Vessel Revascularisation Rates following Isolated Femoropopliteal or Infrapopliteal Endovascular Revascularisation for Chronic Limb Threatening Ischaemia: Insights from the SWEDEPAD 1 TrialTom Le Corvec, Mårten Falkenberg, Peter Gillgren, et al.European Heart Journal|September 28, 2020
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillationLars Wallentin, Johan Lindbäck, Niclas Eriksson, et al.Journal of the American Heart Association|March 26, 2024
Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE TrialKonstantinos I Gkarmiris, Johan Lindbäck, John H Alexander, et al.Journal of Thrombosis and Haemostasis : JTH|August 14, 2021
Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulationAgneta Siegbahn, Johan Lindbäck, Ziad Hijazi, et al.American Heart Journal|March 29, 2023
Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC-AF risk scoresZiad Hijazi, Johan Lindbäck, Jonas Oldgren, et al.JAMA Cardiology|August 25, 2021
Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary SyndromeGorav Batra, Tatevik Ghukasyan Lakic, Johan Lindbäck, et al.Journal of the American Heart Association|September 1, 2020
Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial FibrillationZiad Hijazi, Christopher B Granger, Stefan H Hohnloser, et al.Journal of the American Heart Association|May 8, 2020
Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical TherapyMika Hilvo, Lars Wallentin, Tatevik Ghukasyan Lakic, et al.American Heart Journal|May 15, 2022
Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state modelJulia Aulin, Ziad Hijazi, Johan Lindbäck, et al.Pageof 10